Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Centrexion Therapeutics Corporation    CNTX

CENTREXION THERAPEUTICS CORPORATION

(CNTX)
 SummaryQuotesNewsCompany 
Company
Centrexion Therapeutics Corp is a late clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing therapies to address the unmet medical need for the treatment of chronic pain. Its product candidate pipeline includes CNTX-4957, CNTX-0290,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on CENTREXION THERAPEUTICS CO
09/17Centrexion Therapeutics Announces Completion of Patient Enrollment in VICTORY..
GL
09/04CORRECTION - Centrexion Therapeutics
GL
09/04Centrexion Therapeutics Announces CNTX-4975, CNTX-0290 and CNTX-6970 Data Pre..
GL
07/18Centrexion Therapeutics to Present New Positive Clinical Trial Results on Str..
GL
06/11Centrexion Therapeutics to Announce CNTX-4975 Trial Results at the European L..
GL
06/05Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal..
GL
04/29Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 Br..
GL
03/27Centrexion Therapeutics Announces Publication of Phase 2 Efficacy Data on CNT..
GL
03/07Centrexion Therapeutics Announces CNTX-4975 Preclinical and Clinical Data Pre..
GL
2018Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal..
GL
2018Centrexion steps back from IPO amid volatile market
AQ
More news
News in other languages on CENTREXION THERAPEUTICS CO

- No features available -

More news
Sector news : Biopharmaceuticals
02:48aJ&J Recalls Baby Powder For Asbestos -- WSJ
DJ
10/18More Money Demanded in Opioid Settlement Talks -- Update
DJ
10/18More Money Demanded in Opioid Settlement Talks
DJ
10/18JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 2nd Update
DJ
10/18Sanofi pulls Zantac from U.S. and Canada after carcinogen found
RE
More sector news : Biopharmaceuticals
Chart CENTREXION THERAPEUTICS CORPORATION
Duration : Period :
Centrexion Therapeutics Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Jeffrey B. Kindler Chief Executive Officer & Director
James N. Campbell President, Director & Chief Scientific Officer
Sol J. Barer Chairman
Nick Harvey CFO, Treasurer, Principal Accounting Officer & EVP
Randall M. Stevens Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CENTREXION THERAPEUTICS CORPORATION0.00%0
CSL LIMITED36.42%77 980
BIOGEN INC.-26.87%40 589
ALEXION PHARMACEUTICALS2.70%22 066
SAMSUNG BIOLOGICS CO LTD--.--%19 301
GRIFOLS19.13%18 295